People | February 20, 2022
Resolution Therapeutics strengthens its team with two new appointments
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
He has over 22 years of experience in pharmaceutical sales & business development
It is a novel oral NLRP3 inflammasome inhibitor
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
The product will be commercialized from Unichem's Ghaziabad plant
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
